Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Vanderbilt Report: Artelo Biosciences Expands Into $16.3 Billion Glaucoma Market With Fully Funded Clinical Study
ARISTOTLE (NASDAQ: ARTL) Delayed: 1.23 -0.03 (2.38%)
Previous Close $1.26    52 Week High $6.22 
Open $1.24    52 Week Low $2.74 
Day High $1.27    P/E N/A 
Day Low $1.23    EPS $-0.21 
Volume 105,493